Recent revision of the 0 serotyping scheme for Serratia marcescens has allowed the definitive serological identification of a collection of 51 1 epidemiologically distinct strains in terms of both lipopolysaccharide (0) antigens and capsular (K) antigens. High levels of typability were achieved, 88% and 91y0 respectively, with only 2% failing to type with either method. In most cases, non-typability was due to a lack of antigen, i.e., the strains produced only rough LPS or were acapsular, suggesting that typability would be little improved by the discovery of additional serotypes. The distribution of the 58 O:K serotypes was very uneven, with 014:K14 accounting for 30% of the 423 clinical strains in the collection, but only 5% of the 88 non-clinical, environmental strains. Thus, the prevalence of 014:K14 strains in hospitals is not reflected in the environment. Similar conclusions were valid for 027:K14, 021:K3 and 021:K14 strains, as well as those with rough lipopolysaccharide. Conversely, the proportions of 06:K3, 06:K14, 08:K14 or 028:K28 strains were significantly lower among the clinical collection than among their environmental counterparts (12% in total rather than 65%). This suggests that 014:K14 may have a selective advantage in colonising or infecting hospitalised patients and, therefore, that the 014 and K14 polysaccharides themselves may contribute towards the apparent pathogenicity of these serotypes.
Introduction
Serratia marcescens is a small, gram-negative bacillus belonging to the family Enterobacteriaceae. For many years it was considered a harmless saprophyte and has frequently been isolated from plant materials [l] as well as water and soil [2] . It is a primary pathogen of insects [3, 4] , but rarely, if at all, of man. However, since the late 1950s this organism has been increasingly identified as the cause of various hospitalacquired infections, and it is now recognised as a significant opportunist human pathogen.
In common with other nosocomial pathogens, S. marcescens has been the subject of many epidemiological investigations to identify possible outbreaks and common sources of infection. In the process, several typing systems have been described. One such is 0 serotyping, based on the detection of lipopoly-saccharide (LPS) 0 antigens. In other gram-negative bacteria, 0 typing is a highly definitive technique, but the 5' . marcescens scheme has been plagued with cross-reactions and poor reproducibility [5, 6] . Recent chemical and immunological studies of the LPSs of the 0 serotype strains [7, 81 have allowed the development of a new 0 typing scheme so that, for the first time, the LPS 0 types of this species can be identified with reasonable accuracy. These studies also revealed the presence of acidic polysaccharides in the form of capsules and derived from them a complementary K-typing scheme.
Highly discriminatory systems exist for typing S. marcescens, generating DNA fingerprints ideal for strain comparisons, but unsuited for definitive strain typing of large populations. Serotypes, in addition to providing information on strain relationships, reveal biologically valid groups of strains that may be of value in population studies. This present study used the new 0 and K serotyping assays to characterise a collection of clinical and environmental strains; firstly to determine the typability and discrimination of these methods, and secondly to compare serotype distributions between the two populations.
Materials and methods

SDS-PAGE and silver staining
Crude LPS extracts were prepared, electrophoretically separated and silver-stained as described previously [12] . The resulting LPS profiles were categorised as 'rough' if only low mol. wt material was visible and 'smooth' if the typical LPS ladder pattern was present.
Bacterial strains
The 423 clinical strains used in this study were also utilised in the development of the 0 and K typing schemes [8] , having been chosen from >3000 isolates sent to the Central Public Health Laboratory (CPHL) between 1 Jan. 1980 and 30 June 1990 for epidemiological typing. They were selected to represent distinct strains based on their origin and the original serotyping and phage typing data [5, 61.
Twenty-nine strains from insects, plants and rodents were a gift from Drs P. and F. Grimont, Institut Pasteur, Paris, France. A further 42 environmental strains from insects and soil samples were received from Dr M. 0' Callaghan, AgResearch (Pastoral Agricultural Research Institute), Lincoln, New Zealand. Seventeen other strains, from plants, animals and water, were obtained either from the National Collection of Type Cultures or were selected from those sent to CPHL for identification or typing.
All strains were maintained on nutrient agar or glycerol agar [9] and stored at -20°C on 2-mm glass beads in glycerol 20% w/v broth.
Species conJirmation
Tests for the differentiation of the genus Serratia, as described by Farmer et al. [lo] , were used to confirm the identity of the S. marcescens strains. The various media were inoculated from an overnight tryptone soya broth (TSB) culture and incubated at 30°C for up to 5 days, as recommended by Grimont et al. [2] . Isolates that produced atypical results were tested further by the CPHL Computer Identification Laboratory [ 1 11.
Sero type iden tlfica tion
Both 0 and K serotypes were determined by ELISA with adsorbed rabbit antisera as described previously. Autoclaved organisms grown in tryptone soya broth at 37°C overnight were used for the detection of 0 antigens, and formalinised cells grown on glycerol agar overnight at 30°C for the detection of K antigens [8] .
Briefly, the ELISA plates were coated with whole-cell suspensions at an absorbance of 0.06 at 600 nm in carbonate buffer, before incubation with the panel of antisera. Positive reactions were detected with a goat anti-rabbit IgG-alkaline phosphatase conjugate and Sigma 104 phosphatase substrate.
Serotypes 010 and 022, 016 and 020, and 018 and 029 were merged for convenience as 010/22, 016/20 and 018/29, as within each pair the 0 antigens are similar both chemically and serologically and all had frequencies of < 2%.
Capsule detection
The presence or absence of capsules was determined by the microscopic examination of cell suspensions mixed with Indian ink as a negative stain, as well as indirectly by the Cetavlon technique [7] . This method involves horizontal electrophoresis of crude capsular extracts followed by precipitation with Cetavlon, a cationic detergent that binds acidic but not neutral polysaccharides.
Statistical methods
Associations between the serotype and source were tested for statistical significance by the x2 test or
Fisher's exact test. The Yates' correction for noncontinuous data was applied to the x2 test with one degree of freedom, while Fisher's exact test was used when one or more of the expected values was S 0.5.
Results
Species identlfication
In all, 485 (95%) of the 51 1 strains met the criteria for identification as S. marcescens. The remaining 26 strains were confirmed as S. rnarcescens by extended biochemical tests. The most frequently discrepant test was non-fermentation of sorbitol, which occurred in nine strains. Negative gelatinase, lysine decarboxylase or ornithine decarboxylase test results occurred in c. 1% of the collection, whereas only two strains failed to produce DNAase or lipase (Table 1) .
Two further tests (pigment production and adonitol fermentation), which aid the differentiation of the species within the genus Serratia, are variable characteristics in the species S. marcescens. Of this collection, 93 were pigmented while 5 1 fermented adonitol. It was notable that a much higher proportion of the environmental collection (61 %) was pigmented than the clinical collection (9%).
Source
The 88 environmental strains originated from insects (63%), the natural environment (plants and water, 23%) and animals (14%). The 423 clinical strains, i.e., those which originated from hospitals, included 1 14 for which a source was not known. Among the others, only the urine (81/423, 19%), blood (69/423, 16%) and respiratory tract (61 /423, 14%) strains accounted for > 7% of the clinical collection and were therefore large enough to allow inter-source comparisons of their 
serotype distributions. The remaining 98 clinical strains (from wound, hospital environment, peritoneal fluid, faeces, skin, eye, breast milk and cerebrospinal fluid specimens) were grouped together as 'other'. As the collection was not random, the distribution of sources could only be taken as a rough guide to the true clinical distribution. The relatively high numbers of strains from urine, blood and respiratory tract were consistent with the fact that S. marcescens is typically a non-enteric nosocomial pathogen. This feature of S. marcescens also explains the absence of statistically significant associations between clinical source and either 0 serotype or K serotype (p > 0.05). Thus Fig. 1 compares the 0 and K serotype distributions between clinical strains as a single group and environmental strains. No significant difference was observed for the K-type distributions (p > 0.05), but the 0 serotype frequencies varied markedly (p < 0.001) between clinical and environmental strains.
Distribution of 0 and K serotypes
Among the clinical strains, both distributions were very uneven, with 014 and K14 by far the most common types (Fig. 1) . Frequencies > 5 % were only found for three other 0 serotypes (021, 027 and 028) and two other K serotypes (K28 and K3). Similar percentage frequencies were found among the K serotypes of the environmental collection, but the 0 serotype distribution was clearly different, although still uneven. Among this collection, 0 6 and 0 8 were the most common; together they accounted for almost half of these strains, while a further 17% were 028. In contrast, these three serotypes accounted for only 14% of the clinical collection. Conversely, 0 14, the predominant clinical type, was only represented by 5% of the environmental strains. This difference in distribution of 014 strains between clinical and environmental strains was highly statistically significant, p < 0.0001. One serotype, 024, was not represented in either collection.
Typability was 88% for the O-ELISA and 91% for the K-ELISA, but 98% overall. Of the 59 strains that failed to 0 serotype, 45 (76%) were shown by SDS-PAGE and silver staining to have rough LPS profiles, indicating that these strains lacked 0 antigen. Similarly, 29 (69%) of the 42 K-non-serotypable strains were found to be acapsular by Indian ink staining and the Cetavlon technique. A further difference between the 0 serotype distributions of clinical and environmental collections was that nontypable strains among the former were generally rough (44/53, 83%), whereas non-typable strains from the natural environment tended to have smooth LPS and may have represented undiscovered serotypes.
The original 0 serotype of 356 of the clinical strains had been obtained by agglutination with unadsorbed antisera [ S ] . These results were compared with the ELISA results to determine whether there was any improvement in typability and discrimination. By agglutination, 10 1 strains had been either non-typable or polyagglutinable giving only 72% typability, compared with 87% and 91% of these 356 strains by the 0 typing and K typing ELISAs respectively, and 97% when combined. Over half (187, 53%) of this smaller collection were 014 by agglutination, and a third of these were re-allocated to other 0 types, notably 027, 021, 0 8 and 06, leaving only 34% as 014. There were very few obvious correlations between 0 type and original agglutination type, which seemed to correlate better with K type. All but six of the 187 014-agglutinating strains were shown to be K14, while '03', '04' and '05' were highly correlated with K3 (18/20), K4 (12/14) and K28 (12/12), respect ive 1 y. Table 2 shows the relationships between 0 type and K type which were clearly non-random, although there were only four 100% correlations: all 37 0 8 strains had a K14 capsule, the three K2 strains were 02, the 10 K9 strains were 026, and the three K12 strains were all 014. In total there were 58 combinations of 0 and K type among the 511 strains (if rough and acapsular strains are included as non-typable), with 19 combinations represented by only a single strain. Most of the 014 strains were also K14 while other strong correlations were 0 4 and 027 with K14, 0 5 and 028 with K28, and 0 6 and 021 with both K3 and K14.
Associations between 0 and K serotype
Most 0 types were found with only three or four different K types, although 026 occurred in six combinations. This number of combinations was also found among the K3, K13 and K28 strains. K14 was the most widely distributed type, as would be expected from its high frequency and its history of involvement in cross-reactions.
The distribution of O:K serotype combinations was also significantly associated with source in that 30% of clinical strains were 014:K14 compared with only 5% of environmental strains (p <: 0.0001). A similarly skewed result was seen with 027:K14 with frequencies of 12% and 1% respectively (p<O.Ol). Four serotypes were found with frequencies of 10% or more among the environmental collection, namely 06:K3, 06:K14, 08:K14, 028:K28 which together accounted for 65% of these strains, but only 15% of the clinical strains (for each serotype, p < 0.001).
Incident size
The clinical strains were also classified in terms of the size of the incident from which they originated, on the R, rough LPS assumption that strains producing significant crussinfection may be more pathogenic in man than strains affecting single individuals. This analysis revealed that almost half (198/423, 47%) were apparently unique, i.e., produced sporadic infection only. This number included 10 strains from the hospital environment that did not appear to have been isolated from any patients. About a third (134/423, 32%) were representatives of small outbreaks (two to four patients), while 22% (91/423) of strains were from outbreaks involving at least five patients; thus over 50% of the collection were associated with cross-infection.
The differences in distribution of sporadic and epidemic strains within each 0 type were of only borderline statistical significance (p = 0.04), but there was a tendency for the more common types, such as 0 1 4 and 027, to be associated with epidemic rather than sporadic strains (c. 60:40). The converse was true of the less frequent serotypes such as 0 6 , 0 8 and 028, which were more prevalent in the sporadic category (c. 40:60). There were no statistically significant associations among the K types, although it was noticeable that the acapsular group was the one with the highest proportion of sporadic strains (68%). Rough strains were also more frequently associated with sporadic than epidemic strains (66%).
Discussion
When used in combination, the 0 and K serotyping ELISAs provided a high level of typability with only 2% of the 5 11 strains proving to be completely non-typable. Given that, particularly among clinical strains, most non-typability was due to antigen absence (i.e., rough or acapsular strains) rather than the presence of new antigens, it is unlikely that the addition of further types to the schemes would prove of much benefit in terms of additional discrimination. This conclusion is supported, at least for the 0 serotype scheme, by the fact that there was no predominant LPS profile among the 14 smooth non-typable strains. The high level of typability contrasted favourably with the 72% typability rate of the smaller collection for which 0 agglutination results were available, and with previously published rates (Table 3 ) [6, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] . Comparison between old and new serotypes confirmed that the original 0 typing scheme was a mixture of 0 and K antigens, and that the agglutination method tended to detect K antigens, where present. One result was an apparent reduction in frequency of the 0 1 4 antigen, from 53% by agglutination to 28% by ELISA, largely because the use of adsorbed antisera allowed the detection of 0 antigen independently of capsule. This revealed that the K14 capsule occurred in combination not only with 0 6 , 0 8 , 0 1 4 and 0 2 1 as had been described previously by Gaston et al. [23] , but also with 0 4 , 023, 0 2 6 and 027, as well as both capsular and acapsular K-nontypable strains.
The findings presented here indicate that, in the majority of cases, a combination of 0 and K serotyping should provide satisfactory discrimination of strains within hospital outbreaks. An additional typing method will be necessary to confirm strain identity among 014:K14 isolates, as this was by far the commonest type. The only other type to account for > 10% of the clinical strains was 027:K14, while the corresponding environmental serotypes were 06:K3, 06:K14, 08:K14 and 028:K28. The characterisation of non-serotypable strains will also require a second typing method. In these cases it is likely that a genotypic method may prove the most satisfactory supplement. For example, ribotyping has been shown to produce results consistent with known epidemiology and biotyping [24] , and to provide reliable strain discrimination when combined with biotyping or serotyping [25] . Pulsed-field gel electrophoresis of bacterial DNA digested with rare cutting enzymes also discriminates S. marcescens to strain level [26] , as does DNA fingerprinting by the polymerase chain reaction [27] . For small investigations, the drawbacks of these methodsnamely high cost, labourintensiveness and lack of definitive strain labelsmay well be outweighed by the advantage of good discrim ination.
The uneven distribution of serotype, and in particular the predominance of 0 14:K14 clinical strains, suggested that these two types might be more prone to producing infections than other types. The alternative explanation, that this distribution of types simply reflects the frequencies with which these types are encountered in the environment, was clearly not supported by the serotype distribution seen among the environmental collection. Thus, the serotypes prevalent in the environment (06:K3, 06:K14, 08:K14 and 028:K28) are uncommon in hospitals. Furthermore, the dominant clinical serotype, 0 14:K14, while accounting for a third of clinical strains, represented only 5% of the environmental material. This suggests that selective pressures have been brought to bear in the clinical environment, which have favoured the survival of 0 1 4 strains in preference to those of other 0 types. Consequently, it can be hypothesised that either 0 antigens themselves are virulence factors influencing the pathogenicity of S. marcescens, or that they are closely associated with such factors. In this context it is interesting to compare the serotype distributions reported for this species since 1957 (Table 3) . Direct comparisons are difficult to make because the reports used agglutination techniques that fail to differentiate 0 and K antigens. However, it is notable that 0 1 4 was not added to the serotyping scheme until the third study of S. marcescens serotyping, when it accounted for only 14% of isolates tested. High frequencies of 0 1 4 were not seen until the 1970s; 20 years after the first report on serotyping of this species. Furthermore, the observation that acapsular and rough strains tended to be associated with sporadic rather than epidemic strains supports the idea that the surface polysaccharides typed as 0 and K antigens have a role in the pathogenicity of this species.
The results of this study demonstrated that the new 0 and K serotyping assays are discriminatory and no longer suffer from high levels of non-typability. Furthermore, they also demonstrate a significant difference in the distribution of serotypes between clinical and environmental strains, suggesting that the surface polysaccharides represented by these antigens may be involved in the selection of strains within the clinical setting.
